98510-20-4Relevant articles and documents
myo-inositol 4,6-carbonate: An easily prepared small molecule with three syn-axial hydroxyl groups
Angyal
, p. 313 - 320 (2000)
myo-Inositol 4,6-carbonate, a compound having three syn-axial hydroxyl groups, was synthesized in four steps suitable for gram-scale preparation. It readily forms complexes with cations.
First synthesis of 3-O-methyl-scyllo-inosamine, a natural product which favors the Rhizobium-Leguminosae symbiosis
Krief, Alain,Dumont, Willy,Billen, Denis,Letesson, Jean-Jacques,Lestrate, Pascal,Murphy, Peter J.,Lacroix, Damien
, p. 1461 - 1463 (2004)
Rhizopine, extracted in small amounts from nodules induced by Sinorhizobium meliloti strain L5-30 infection of alfalfa, was proved to possess the 3-O-methyl-scyllo-inosamine gross structure.
2-O-Benzoyl-myo-inositol-1,3,5-orthoformate
Samanta, Uttamkumar,Puranik, Vedavati G.,Chakrabarti, Pinak,Thoniyot, Praveen,Shashidhar, Mysore S.
, p. 1289 - 1291 (1998)
Protected myo-inositol derivatives are important precursors in the synthesis of phosphorylated myo-inositol derivatives, which play a significant role in cellular signal transduction. The structure of the title compound, C14H14O
ACETYLATED PRODRUGS FOR DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
-
Page/Page column 32 - 34, (2019/11/12)
The present disclosure relates to pharmaceutical compositions including a compound derived from a parent compound having a hydroxyl or amino moiety, wherein the hydroxyl in the parent compound is presented as an ester in the compound or the amino in the parent compound is presented as an amide in the compound, and their use to prevent or treat neurological disease.
4,6-DI-(O-THIOPHOSPHATE)-INOSITOL-1,2,3,5-TETRA-O-SULFATE FOR C. DIFFICILE INFECTION
-
Page/Page column 4, (2017/07/23)
The present invention relates to inositol bisthiophosphates-tetrakissulfates, particularly for use in treating symptoms associated with Clostridium difficile infection.
Phosphoric acid phaseomannite class compound and its preparation method and application (by machine translation)
-
Paragraph 0355-0357; 0358, (2017/07/14)
The invention discloses a phaseomannite class phosphate compound, phosphoric acid phaseomannite class compound preparation method, and these phosphoric acid phaseomannite class compounds in the preparation of an anti-tumor drug. The use of non-small cell lung cancer cells to the compounds of this invention to inhibit the growth of tumor cells in active testing, that the compounds of this invention have high inhibition of tumor cell growth activity, some of the compound inhibiting activity even with cisplatin active quite, which indicates that the compounds of this invention have good cell penetrability and phosphorus esterase stability, can be used for the development of anti-tumor medicament. (by machine translation)